Vancouver, British Columbia--(Newsfile Corp. - March 13, 2026) - Thor Explorations (TSXV: THX) (AIM: THX) ("Thor" or the "Company") is pleased to announce that the Company has filed on SEDAR+ (here) ...

The randomized, double-blind, placebo-controlled, multicenter study enrolled 992 patients globally. The intent-to-treat ...

Bristol Myers Squibb has the first positive phase 3 results under its belt for mezigdomide, a second experimental drug in its much-trumpeted celmod development programme for multiple myeloma.

Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production to a CDMO can reduce cost, risk, and time to market while ensuring ...

Q4 2025 earnings call: ivonescimab Phase III updates, FDA PDUFA timeline, interim PFS in Q2 2026, cash position—read now.

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, provided a business update and ...

Michael Shea serves as chairman and CEO of Elevate Patient Financial Solutions Based in Spring, Texas, Elevate PFS provides revenue cycle management services to healthcare providers Elevate Patient ...

Pooled trials show Pluvicto improves progression-free survival in advanced prostate cancer, without increasing serious adverse events. An examination of data from more than 2500 patients with advanced ...

The FDA has acknowledged receipt of the supplemental Biologics License Application (sBLA) for nogapendekin alfa inbakicept-pmln (Anktiva) plus Bacillus Calmette-Guérin (BCG) in BCG-unresponsive ...

The U.S. Food and Drug Administration (FDA) declined approval of retifanlimab-dlwr for patients with metastatic non-small cell lung cancer (NSCLC) in the United States because of manufacturing ...

Ohio doesn’t tax Social Security benefits. Here’s how the state’s income and property taxes affect retirees.

MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help ...